Contineum
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Contineum and other ETFs, options, and stocks.About CTNM
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S.
CEOCarmine N. Stengone
CEOCarmine N. Stengone
Employees41
Employees41
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2017
Founded2017
Employees41
Employees41
CTNM Key Statistics
Market cap106.59M
Market cap106.59M
Price-Earnings ratio-1.89
Price-Earnings ratio-1.89
Dividend yield—
Dividend yield—
Average volume86.37K
Average volume86.37K
High today$4.15
High today$4.15
Low today$3.71
Low today$3.71
Open price$3.71
Open price$3.71
Volume35.99K
Volume35.99K
52 Week high$22.00
52 Week high$22.00
52 Week low$3.35
52 Week low$3.35
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CTNM. This list is generated using Robinhood data, and it’s not a recommendation.